Fintel reports that on April 7, 2025, Maxim Group initiated coverage of Intchains Group Limited - Depositary Receipt () ...

In a report released yesterday, Tate Sullivan from Maxim Group maintained a Buy rating on Beam Global (BEEM – Research Report). The company’s ...

Maxim Group analyst Michael Okunewitch maintained a Buy rating on Lineage Therap (LCTX – Research Report) yesterday and set a price target of ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...

Fintel reports that on April 4, 2025, Maxim Group downgraded their outlook for Galmed Pharmaceuticals (NasdaqCM:GLMD) from Buy to Hold. Analyst Price Forecast Suggests 813.43% Upside As of December 3, ...

Maxim Group assumed coverage on shares of Nuvectis Pharma (NASDAQ:NVCT – Free Report) in a research note issued to investors on Wednesday morning, MarketBeat reports. The firm issued a buy rating and ...

AGP Prime, the prime brokerage division of A.G.P. / Alliance Global Partners, has appointed David Miller as Senior Managing ...

Discover key insights from The Lovesac Company's Q4 2025 earnings call! Learn about innovative product launches, fiscal 2026 projections, and ...

Trump's worldwide tariffs are putting the squeeze on several high-profile L.A.-based toy makers and apparel companies.

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...